Purpose Beyond a Cure: Advancing Hodgkin Lymphoma Treatment
UF researcher William Slayton has led clinical trials that aim to reduce the burden of side effects for Hodgkin lymphoma patients like Emilie Lynch, who has passed the 5-year milestone considered a yardstick for being cured.
